Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients.
Federica GuaraldiLuca MorandiMatteo ZoliDiego MazzatentaAlberto RighiStefania EvangelistiFrancesca AmbrosiCaterina TononCaterina GianniniRicardo V LloydSofia AsioliPublished in: Clinical endocrinology (2022)
Somatic mutations and methylation levels of genes involved in cell proliferation/differentiation, miRNA/LncRNA-post-transcriptional regulators and targets of antineoplastic therapies are different in non-aggressive and in aggressive PAs/PitNETs. Methylation profile also varies according to gender. Combined genetic-epigenetic analysis, in association with clinico-radiological-pathological data, may be of help in predicting PA/PitNET behaviour.